Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brugia malayi | 11 | 2015 | 41 | 2.080 |
Why?
|
| Antigens, Helminth | 8 | 2014 | 178 | 1.630 |
Why?
|
| Filariasis | 7 | 2013 | 24 | 1.620 |
Why?
|
| Murinae | 6 | 2014 | 10 | 1.030 |
Why?
|
| Elephantiasis, Filarial | 3 | 2013 | 14 | 0.930 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 2 | 2018 | 32 | 0.800 |
Why?
|
| Vaccines | 3 | 2013 | 389 | 0.690 |
Why?
|
| Immunoglobulin G | 5 | 2014 | 1021 | 0.590 |
Why?
|
| Vaccines, DNA | 2 | 2013 | 105 | 0.520 |
Why?
|
| Helminth Proteins | 2 | 2013 | 107 | 0.520 |
Why?
|
| Receptors, Histamine | 1 | 2013 | 7 | 0.460 |
Why?
|
| Histamine | 1 | 2013 | 53 | 0.450 |
Why?
|
| Biolistics | 1 | 2012 | 2 | 0.440 |
Why?
|
| Immunoglobulin E | 1 | 2013 | 163 | 0.430 |
Why?
|
| Peritoneal Cavity | 1 | 2011 | 56 | 0.400 |
Why?
|
| Antibodies, Helminth | 6 | 2014 | 105 | 0.400 |
Why?
|
| Immune Evasion | 1 | 2011 | 73 | 0.390 |
Why?
|
| Glioblastoma | 2 | 2018 | 1797 | 0.370 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 2927 | 0.360 |
Why?
|
| Virulence Factors | 1 | 2011 | 213 | 0.360 |
Why?
|
| Antigenic Variation | 2 | 2018 | 38 | 0.320 |
Why?
|
| Vaccination | 2 | 2014 | 1123 | 0.310 |
Why?
|
| T-Lymphocytes | 5 | 2020 | 3869 | 0.300 |
Why?
|
| Interferon-gamma | 4 | 2014 | 1144 | 0.280 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2020 | 1763 | 0.280 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 4849 | 0.250 |
Why?
|
| Leishmania donovani | 2 | 2015 | 13 | 0.220 |
Why?
|
| Leishmaniasis, Visceral | 2 | 2015 | 13 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2020 | 1146 | 0.220 |
Why?
|
| Interleukin-4 | 2 | 2013 | 284 | 0.210 |
Why?
|
| Polyesters | 2 | 2013 | 53 | 0.210 |
Why?
|
| Cerebrospinal Fluid | 1 | 2020 | 120 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 3 | 2013 | 2314 | 0.170 |
Why?
|
| Muscle Neoplasms | 1 | 2020 | 109 | 0.170 |
Why?
|
| Receptor, ErbB-2 | 2 | 2020 | 2518 | 0.170 |
Why?
|
| Leukemia, B-Cell | 1 | 2020 | 117 | 0.170 |
Why?
|
| Immunologic Memory | 1 | 2021 | 374 | 0.170 |
Why?
|
| Animals | 18 | 2021 | 59536 | 0.170 |
Why?
|
| Gerbillinae | 3 | 2013 | 52 | 0.160 |
Why?
|
| Ependymoma | 1 | 2020 | 242 | 0.150 |
Why?
|
| Immunization | 3 | 2015 | 397 | 0.150 |
Why?
|
| Receptor, EphA2 | 1 | 2018 | 132 | 0.150 |
Why?
|
| Rhabdomyosarcoma | 1 | 2020 | 341 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2021 | 709 | 0.150 |
Why?
|
| Antigens, CD19 | 1 | 2020 | 577 | 0.140 |
Why?
|
| Nitric Oxide | 4 | 2014 | 644 | 0.140 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 86 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2014 | 568 | 0.130 |
Why?
|
| Enzyme Activators | 1 | 2014 | 20 | 0.130 |
Why?
|
| Medulloblastoma | 1 | 2020 | 540 | 0.130 |
Why?
|
| Larva | 2 | 2013 | 274 | 0.120 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 697 | 0.120 |
Why?
|
| Immunity, Cellular | 2 | 2013 | 419 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 261 | 0.120 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2013 | 84 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2014 | 1538 | 0.110 |
Why?
|
| Immunization, Secondary | 1 | 2013 | 110 | 0.110 |
Why?
|
| DNA, Helminth | 1 | 2012 | 22 | 0.110 |
Why?
|
| Injections, Intradermal | 1 | 2012 | 58 | 0.110 |
Why?
|
| Antibody Specificity | 1 | 2013 | 334 | 0.110 |
Why?
|
| Immunity, Active | 1 | 2012 | 14 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2013 | 383 | 0.110 |
Why?
|
| Cytokines | 4 | 2020 | 2809 | 0.100 |
Why?
|
| COS Cells | 1 | 2012 | 377 | 0.100 |
Why?
|
| India | 1 | 2012 | 301 | 0.100 |
Why?
|
| Interleukin-12 | 1 | 2012 | 253 | 0.100 |
Why?
|
| Spleen | 1 | 2013 | 676 | 0.100 |
Why?
|
| Filaricides | 1 | 2010 | 5 | 0.100 |
Why?
|
| Flavanones | 1 | 2010 | 11 | 0.100 |
Why?
|
| Plant Preparations | 1 | 2010 | 36 | 0.100 |
Why?
|
| Anthelmintics | 1 | 2010 | 69 | 0.090 |
Why?
|
| Helminths | 1 | 2010 | 37 | 0.090 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2010 | 84 | 0.090 |
Why?
|
| Hepatitis B Vaccines | 1 | 2010 | 51 | 0.090 |
Why?
|
| Mice | 7 | 2021 | 34495 | 0.090 |
Why?
|
| Cell Proliferation | 5 | 2018 | 7226 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 657 | 0.090 |
Why?
|
| Helminthiasis | 1 | 2010 | 67 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 461 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2011 | 403 | 0.090 |
Why?
|
| Flavonoids | 1 | 2010 | 188 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2010 | 327 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2009 | 257 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2009 | 250 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 3821 | 0.070 |
Why?
|
| Male | 10 | 2020 | 123000 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 7789 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2013 | 84 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 10035 | 0.050 |
Why?
|
| Inflammation | 1 | 2012 | 2522 | 0.050 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2014 | 212 | 0.050 |
Why?
|
| Particle Size | 2 | 2013 | 182 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 5395 | 0.050 |
Why?
|
| Injections, Subcutaneous | 2 | 2013 | 334 | 0.050 |
Why?
|
| Microspheres | 2 | 2013 | 210 | 0.050 |
Why?
|
| Cricetinae | 2 | 2015 | 706 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2020 | 114 | 0.050 |
Why?
|
| Humans | 9 | 2020 | 261506 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2020 | 475 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 931 | 0.040 |
Why?
|
| Transgenes | 1 | 2020 | 557 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 582 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2020 | 675 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2020 | 604 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 7222 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 669 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 1489 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 905 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 1914 | 0.030 |
Why?
|
| Mesocricetus | 1 | 2015 | 114 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2020 | 434 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2020 | 32848 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2015 | 219 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 208 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 629 | 0.030 |
Why?
|
| Remission Induction | 1 | 2020 | 3569 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 1869 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1506 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 3438 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2020 | 2358 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 3443 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 325 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 4143 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 3570 | 0.030 |
Why?
|
| Rutin | 1 | 2010 | 2 | 0.020 |
Why?
|
| Hesperidin | 1 | 2010 | 3 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2010 | 54 | 0.020 |
Why?
|
| Cations | 1 | 2010 | 62 | 0.020 |
Why?
|
| Emulsions | 1 | 2010 | 82 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5112 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2010 | 234 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 177 | 0.020 |
Why?
|
| Child | 2 | 2020 | 29154 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1130 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 503 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 1688 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 5047 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2010 | 9180 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2008 | 66 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 702 | 0.020 |
Why?
|
| Immunization Schedule | 1 | 2006 | 117 | 0.020 |
Why?
|
| Thiazoles | 1 | 2010 | 726 | 0.020 |
Why?
|
| Proteome | 1 | 2009 | 561 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 5637 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 14551 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 13310 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2020 | 16273 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 7591 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2008 | 1234 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 12926 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2008 | 2967 | 0.010 |
Why?
|
| Female | 2 | 2020 | 141928 | 0.010 |
Why?
|